Literature DB >> 399938

Changes in plasma renin activity in cirrhosis: a reappraisal based on studies in 67 patients and "low-renin" cirrhosis.

S P Wilkinson, I K Smith, R Williams.   

Abstract

The generally held views that plasma renin activity (PRA) is increased in cirrhosis and that this is secondary to reductions in the "effective" blood or extracellular fluid (ECF) volumes, consequent on the effects of portal hypertension, were re-examined in the present study. Measurements of PRA in 67 patients representing different clinical stages of cirrhosis showed that the mean value in 15 patients without ascites was significantly reduced. In 21 of 35 with ascites, PRA was either reduced or within the normal range. A low plasma renin substrate concentration was not the cause for the low PRA. These findings are not in keeping with the concepts of reduced "effective" blood or ECF volumes at least for the majority of patients at these stages of cirrhosis under the conditions of the present study. The only group showing a significantly increased PRA had evidence of renal impairment. In these 17 patients the underlying reduction in renal perfusion may have been the stimulus to the kidney that led to an increase to renin secretion.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 399938     DOI: 10.1161/01.hyp.1.2.125

Source DB:  PubMed          Journal:  Hypertension        ISSN: 0194-911X            Impact factor:   10.190


  12 in total

1.  Clinical and hormonal conditions associated with sodium retention in cirrhotic patients with ascites. Evaluation by univariate and multivariate analyses.

Authors:  S Gentile; M Angelico; M G Chiappini; G Peruzzi; S Vulterini
Journal:  Dig Dis Sci       Date:  1987-06       Impact factor: 3.199

2.  [Effect of captopril therapy on sodium and water excretion in patients with liver cirrhosis and ascites].

Authors:  R Brunkhorst; E Wrenger; K Kühn; F W Schmidt; K Koch
Journal:  Klin Wochenschr       Date:  1989-08-01

3.  Relation between severity of liver disease and renal oxygen consumption in patients with cirrhosis.

Authors:  A Gadano; R Moreau; J Heller; C Chagneau; F Vachiéry; C Trombino; A Elman; C Denié; D Valla; D Lebrec
Journal:  Gut       Date:  1999-07       Impact factor: 23.059

4.  Loss of tubuloglomerular feedback in decompensated liver cirrhosis: physiopathological implications.

Authors:  Giovanni Sansoè; Stefano Silvano; Giulio Mengozzi; Antonina Smedile; Giovanni Touscoz; Floriano Rosina; Mario Rizzetto
Journal:  Dig Dis Sci       Date:  2005-05       Impact factor: 3.199

5.  Renal tubular events following passage from the supine to the standing position in patients with compensated liver cirrhosis: loss of tubuloglomerular feedback.

Authors:  G Sansoè; A M Biava; S Silvano; A Ferrari; F Rosina; A Smedile; A Touscoz; L Bonardi; M Rizzetto
Journal:  Gut       Date:  2002-11       Impact factor: 23.059

6.  Dopaminergic control of renal tubular function in patients with compensated cirrhosis.

Authors:  Giovanni Sansoè; Alberto Ferrari; Enrica Baraldi; Carmen Nives Castellana; Alessandra Biava; Stefano Silvano; Floriano Rosina; Lorenzo Bonardi; Federico Manenti
Journal:  Dig Dis Sci       Date:  2002-02       Impact factor: 3.199

7.  Renin-angiotensin-aldosterone system in cirrhosis.

Authors:  S P Wilkinson; R Williams
Journal:  Gut       Date:  1980-06       Impact factor: 23.059

8.  Aldosterone related blood volume expansion in cirrhosis before and during the early phase of ascites formation.

Authors:  M Bernardi; F Trevisani; C Santini; R De Palma; G Gasbarrini
Journal:  Gut       Date:  1983-08       Impact factor: 23.059

Review 9.  Resistance to diuretics: emphasis on a pharmacological perspective.

Authors:  D C Brater
Journal:  Drugs       Date:  1981-12       Impact factor: 9.546

10.  Enhanced renal ammonia excretion following volume expansion in patients with well compensated cirrhosis of the liver.

Authors:  R Jalan; D Kapoor
Journal:  Gut       Date:  2003-07       Impact factor: 23.059

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.